GT
AUXL

Glenmede Trust’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Glenmede Trust’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-619,525
Closed -$12.4M – 2563
2014
Q2 		$12.4M Buy
619,525
+72,818
+13% +$1.67M 0.11% 263
2014
Q1 		$14.9M Sell
546,707
-33,035
-6% -$877K 0.14% 218
2013
Q4 		$12M Buy
579,742
+209,875
+57% +$3.96M 0.12% 230
2013
Q3 		$6.87M Buy
+369,867
New +$6.68M 0.08% 296

Other funds holding AUXL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Glenmede Trust's AUXL Position: Q3 2014 in Review

Glenmede Trust sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2014, closing a stake of 619,525 shares — an estimated $12.4M sold.

Glenmede Trust first reported a position in AUXL in Q3 2013 and held it in 4 quarters. The position peaked at $14.9M in Q1 2014. 150 funds tracked by Wall St. Rank hold AUXL as of Q3 2014.

  • Glenmede Trust reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Glenmede Trust sold 619,525 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2014, an estimated $12.4M.
  • Glenmede Trust first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q3 2013 and held it in 4 quarters.
  • Glenmede Trust's AUXILIUM PHARAMCEUTICALS INC position peaked at $14.9M in Q1 2014.
  • 150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2014.

Based on Glenmede Trust's 13F filing for Q3 2014, filed 14 Nov 2014.